Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
高級檢索
  • P859: ANTI-CD38 NANOBODY JK36...
  • 引用
  • 發送短信
  • 推薦此
  • 打印
  • 導出紀錄
    • 導出到 RefWorks
    • 導出到 EndNoteWeb
    • 導出到 EndNote
  • Permanent link
P859: ANTI-CD38 NANOBODY JK36 ALLOWS RELIABLE MRD DETECTION IN DARATUMUMAB TREATED MULTIPLE MYELOMA PATIENTS

P859: ANTI-CD38 NANOBODY JK36 ALLOWS RELIABLE MRD DETECTION IN DARATUMUMAB TREATED MULTIPLE MYELOMA PATIENTS

書目詳細資料
Main Authors: E. Meseguer Martinez, J. Marco Buades, A. García Feria, P. Ribas García, M. J. Fernandez Llavador, A. López Gabaldon, S. Broseta Tormos, E. Francés Aracil, O. Cortés Ortega, E. Donato Martínez, M. Fernandez Zarzoso, M. Panero Ruiz, M. J. Cejalvo Andújar, A. Tolosa Muñoz, M. L. Juan Marco, D. Ivars Santacreu, E. Gómez Beltrán, M. J. Sayas Lloris
格式: Article
語言:English
出版: Wiley 2022-06-01
叢編:HemaSphere
在線閱讀:http://journals.lww.com/10.1097/01.HS9.0000846316.26911.4d
  • 持有資料
  • 實物特徵
  • 相似書籍
  • 職員瀏覽

因特網

http://journals.lww.com/10.1097/01.HS9.0000846316.26911.4d

相似書籍

  • P1527: NEXT GENERATION SEQUENCING IN HEREDITARY SPHEROCYTOSIS DIAGNOSIS
    由: A. García Feria, et al.
    出版: (2022-06-01)
  • The JK System to Detect Plagiarism
    由: Khair Eddin M. Sabri, et al.
    出版: (2006-10-01)
  • PHOTOMETRICAL STUDY OF OVERCONTACT BINARY SYSTEM V859Cyg
    由: E. A. Panko, et al.
    出版: (2016-10-01)
  • P889: WILL OUTCOME IMPROVE BY TREATING MULTIPLE MYELOMA PATIENTS AT MRD RELAPSE? THE REMNANT STUDY (RELAPSE FROM MRD NEGATIVITY AS INDICATION FOR TREATMENT)
    由: F. B. Askeland, et al.
    出版: (2022-06-01)
  • MRD-driven phase 2 study of daratumumab, carfilzomib, lenalidomide, and dexamethasone in newly diagnosed multiple myeloma
    由: Manisha Bhutani, et al.
    出版: (2025-02-01)

檢索選項

  • 檢索歷史
  • 高級檢索

查找更多

  • 瀏覽目錄
  • 按字母順序瀏覽
  • Explore Channels
  • 課程儲備
  • 新項目

需要幫助?

  • 檢索技巧
  • 咨詢台
  • 常見問題